Due to the great success of our 2022 CHQ/UQ Clinical Researcher Development Program, we have opened our EOI for 2023! We were overwhelmed with quality applications last year and look forward to a similar tidal wave. Don't forget to discuss you research idea with your line manager before applying.

World Sepsis Day is on September 13th each year. This internationally recognised initiative of the Global Sepsis Alliance aims to increase public awareness and show support and solidarity with the millions of people worldwide whose lives have been affected by sepsis. To support this, the Queensland Paediatric Sepsis Program (QPSP) have developed a digital health promotion pack, designed to increase awareness, education and support for families and empower parents and caregivers of sick children to ask the question, “Could it be Sepsis?” – see the below link. Please consider how your organisation, team, workplace or community can help raise awareness.

https://s3-ap-southeast-2.amazonaws.com/wh1.thewebconsole.com/wh/9767/images/World-Sepsis-Day-Health-Promotion-Pack.pdf

At the beginning of April nurses, midwives and allied health clinicians leading research had some amazing news, which is a huge opportunity for PATTERN members. The Medical Research Future Fund (MRFF) has released dedicated Clinician Researcher funding for nurses, midwives and allied health -see here for more information.

This builds on the prior scheme that was focused on physicians, and is hopefully not the last time this type of funding is dedicated to our workforce, our science and our people. All teams must include early career researchers, so I encourage you to reach out to leaders in your clinical topic areas and be part of the teams.

Congratulations to Prof Amanda Ullman, Prof Samantha Keogh, A/Prof Natalie Bradford, Tricia Kleidon, Rachel Edwards and the entire team on a massive $2 million grant from the Cancer Council Queensland to support their research to prevent healthcare associated harm for children being treated for cancer.

• Cancer Council Queensland, Accelerating Collaborative Cancer Research Grant $2M ($1.4M CCQ; $600K UQ) Preventing adverse events during paediatric cancer treatment: A multi-site hybrid randomised controlled trial of catheter lock solutions.

In this world-first trial, the research team will evaluate the effectiveness of the CVAD lock solution (T-EDTA) compared to usual care (heparin and normal saline) to reduce infections, thromboses and blockages for children being treated for cancer. The team has a PhD scholarship available within the project, and would love to hear from you if you are interested. (a.ullman@uq.edu.au)

For more details, please click here.